Targeting CVD risk in chronic connective tissue disease

Practitioner

Volumn 256, Issue 1747, 2012, Pages 21-26

  Malaviya, Anshuman P ^a   Hall, Frances C ^b  

^a ADDENBROOKE S HOSPITAL   (United Kingdom)

^b UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CARDIOVASCULAR DISEASE; CONFERENCE PAPER; CONNECTIVE TISSUE DISEASE; HUMAN; PATHOLOGY; RISK FACTOR;

CARDIOVASCULAR DISEASES; CONNECTIVE TISSUE DISEASES; HUMANS; RISK FACTORS;

EID: 84857944825     PISSN: 00326518     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (38)

1. Aviña-Zubieta JA, Choi HK, Sadatsafavi M et al. Risk of cardiovascular mortality in patients with rheumatoid arthritis: a meta-analysis of observational studies. Arthritis Rheum 2008;59:1690-7
2. Wolfe F, Mitchell DM, Sibley JT et al. The mortality of rheumatoid arthritis. Arthritis Rheum 1994;37:481-94 (Pubitemid 24115934)
3. Schoenfeld Y, Gerli R, Doria A et al. Accelerated atherosclerosis in autoimmune rheumatic diseases. Circulation 2005;112:3337-3347 (Pubitemid 43739380)
4. Manzi S, Meilahn EN, Rairie JE et al. Age-specific incidence rates of myocardial infarction and angina in women with systemic lupus erythematosus: comparison with the Framingham study. Am J Epidemiol 1997;145:408-15 (Pubitemid 27084212)
5. Maradit-Kremers H, Crowson CS, Nicola PJ et al. Increased unrecognized coronary heart disease and sudden deaths in rheumatoid arthritis: a populationbased cohort study. Arthritis Rheum2005;52:402-411 (Pubitemid 40220344)
6. Solomon DH, Karlson EW, Rimm EB et al. Cardiovascular morbidity and mortality in women diagnosed with rheumatoid arthritis. Circulation 2003;107:1303-7 (Pubitemid 36314415)
7. Peters MJ, Van der Horst-Bruinsma IE, Dijkmans BA, Nurmohamed MT. Cardiovascular risk profile of patients with spondylarthropathies, particularly ankylosing spondylitis and psoriatic arthritis. Semin Arthritis Rheum 2004; 34:585-92 (Pubitemid 39643120)
8. Holmqvist ME, Wedrén S, Jacobsson LT et al. Rapid increase in myocardial infarction risk following diagnosis of rheumatoid arthritis amongst patients diagnosed between 1995 and 2006. J Intern Med 2010;268:578-85
9. Franklin J, Farragher TM, Lunt M et al. Excess risk of hospital admission for cardiovascular disease within the first 7 years from onset of inflammatory polyarthritis. Ann Rheum Dis 2010;69:1660-4
10. del Rincón I, Williams K, Stern MP et al. Association between carotid atherosclerosis and markers of inflammation in rheumatoid arthritis patients and healthy subjects. Arthritis Rheum 2003;48:1833-1840 (Pubitemid 36828677)
11. Jamnitski A, Visman IM, Peters MJ et al. Prevalence of cardiovascular diseases in psoriatic arthritis resembles that of rheumatoid arthritis.Ann Rheum Dis2011;70:875-6
12. Hak AE, Karlson EW, Feskanich D et al. Systemic lupus erythematosus and the risk of cardiovascular disease: results from the nurses' health study. Arthritis Rheum 2009;61(10):1396-402
13. Bruce IN, Gladman DD, Urowitz MB. Premature atherosclerosis in SLE. Rheum Dis Clin North Am 2000;26:257-78
14. Sandborg C, Ardoin SP, Schanberg L. Therapy Insight: cardiovascular disease in pediatric systemic lupus erythematosus. Nat Clin Pract Rheum2008;4(5):258-65 (Pubitemid 351638683)
15. Wajed J, Ahmad Y, Durrington PN, Bruce IN. Prevention of cardiovascular disease in systemic lupus erythematosus-proposed guidelines for risk factor management. Rheumatology2004;43:7-12 (Pubitemid 38088360)
16. Soltész P, Veres K, Lakos G et al. Evaluation of clinical and laboratory features of antiphospholipid syndrome: a retrospective study of 637 patients.Lupus 2003;12(4):302-7
17. Au K, Singh MK, Bodukam V et al. Atherosclerosis in systemic sclerosis: a systematic review and meta-analysis. Arthritis Rheum2011;63(7):2078-90
18. Mukhtyar C, Brogan P, Luqmani R. Cardiovascular involvement in primary systemic vasculitis. Best Pract Res Clin Rheumatol2009;23(3):419-28
19. Suppiah R, Judge A, Batra R et al. A model to predict cardiovascular events in patients with newly diagnosed Wegener's granulomatosis and microscopic polyangiitis. Arthritis Care Res (Hoboken)2011;63(4):588-96
20. Solomon DH, Kremer J, Curtis JR et al. Explaining the cardiovascular risk associated with rheumatoid arthritis: Traditional risk factors versus markers of rheumatoid arthritis severity. Ann Rheum Dis 2010;69(11):1920-1925
21. Myasoedova E, Crowson CS, Kremers HM et al. Lipid paradox in rheumatoid arthritis: the impact of serum lipid measures and systemic inflammation on the risk of cardiovascular disease. Ann Rheum Dis2011;70:482-7
22. Charles-Schoeman C, Watanabe J, Lee YY et al. Abnormal function of high-density lipoprotein is associated with poor disease control and an altered protein cargo in rheumatoid arthritis. Arthritis Rheum 2009;60:2870-9
23. Goligorsky MS. Endothelial cell dysfunction: can't live with it, how to live without it. Am J Physiol Renal Physiol 2005;288:F871-80 (Pubitemid 40569751)
24. Ridker PM, Hennekens CH, Buring JE, Rifai N. C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women. N Engl J Med2000;342:836-43 (Pubitemid 30165206)
25. Kozera L, Andrews J, Morgan AW. Cardiovascular risk and rheumatoid arthritis-the next step: differentiating true soluble biomarkers of cardiovascular risk from surrogate measures of inflammation. Rheumatology (Oxford) 2011;50:1944-54
26. Gerli R, Schillaci G, Giordano A et al. CD4+CD28- T lymphocytes contribute to early atherosclerotic damage in rheumatoid arthritis patients. Circulation2004; 8;109:2744-8
27. Elliott JR, Manzi S. Cardiovascular risk assessment and treatment in systemic lupus erythematosus. Best Pract Res Clin Rheumatol 2009;23:481-94
28. Toloza SM, Uribe AG, McGwin G Jr et al. Systemic lupus erythematosus in a multiethnic US cohort (LUMINA). XXIII. Baseline predictors of vascular events. Arthritis Rheum 2004;50: 3947-57 (Pubitemid 39643943)
29. Sherer Y, Shoenfeld Y. Antiphospholipid antibodies: are they pro-atherogenic or an epiphenomenon of atherosclerosis? Immunobiology 2003;207:13-6 (Pubitemid 36285090)
30. Berglund S, Södergren A, Wållberg Jonsson S, Rantapää Dahlqvist S. Atherothrombotic events in rheumatoid arthritis are predicted by homocysteine - a six-year follow-up study. Clin Exp Rheumatol 2009;27:822-5
31. Karp I, Abrahamowicz M, Fortin PR et al. Recent corticosteroid use and recent disease activity: independent determinants of coronary heart disease risk factors in systemic lupus erythematosus? Arthritis Rheum 2008;59:169-75 (Pubitemid 351272950)
32. Nadareishvili Z, Michaud K, Hallenbeck JM, Wolfe F. Cardiovascular, rheumatologic, and pharmacologic predictors of stroke in patients with rheumatoid arthritis: a nested, case-control study. Arthritis Rheum 2008;59(8):1090-6
33. Peters MJL, Symmons DPM, McCarey D et al. EULAR evidence-based recommendations for cardiovascular risk management in patients with rheumatoid arthritis and other forms of inflammatory arthritis. Ann Rheum Dis 2010;69:325-331
34. Crowson CS, Gabriel SE. Towards improving cardiovascular risk management in patients with rheumatoid arthritis: the need for accurate risk assessment. Ann Rheum Dis 2011;70(5):719-21
35. Wajed J, Ahmad Y, Durrington PN, Bruce IN. Prevention of cardiovascular disease in systemic lupus erythematosus-proposed guidelines for risk factor management.Rheumatology 2004;43:7-12 (Pubitemid 38088360)
36. Hall FC, Dalbeth N. Disease modification and cardiovascular risk reduction: two sides of the same coin? Rheumatology (Oxford) 2005;44(12):1473-82 (Pubitemid 41742462)
37. Grundy SM, Cleeman JI, Merz CN. Coordinating Committee of the National Cholesterol Education Program. A summary of implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines. ArteriosclerThromb Vasc Biol 2004;24(8):1329-30 (Pubitemid 39050420)
38. Joint British recommendations on prevention of coronary heart disease in clinical practice: summary. British Cardiac Society, British Hyperlipidaemia Association, British Hypertension Society, British Diabetic Association.BMJ 2000 11;320(7236):705-8